10 Best Biotech Stocks with Highest Upside Potential
On April 16, reports from J.P. Morgan's biopharma and medtech venture and licensing studies indicated that the capital markets began the year 2026 with selective strength.
Praxis Precision Medicines Inc. (PRAX)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Perceptive Advisors Joseph Edelman | 1,995,986 | $588,296,914 | +28% | 10.49% |
| 2. | Orbis Investment Management William B. Gray | 1,255,162 | $369,946,448 | 1.55% | |
| 3. | Baker Bros. Advisors Julian Baker And Felix Baker | 1,126,488 | $332,021,073 | +64% | 1.94% |
| 4. | Adage Capital Management Phill Gross And Robert Atchinson | 965,313 | $284,516,354 | -60% | 0.43% |
| 5. | Cormorant Asset Management Bihua Chen | 950,000 | $280,003,000 | -5% | 12.95% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.75 | 14,500 | $25,375.00 | 14,500 | 2023-10-05 | Filing | |
| $1.06 | 10,000 | $10,587.00 | 45,002 | 2023-06-27 | Filing | |
| $0.87 | 8,000 | $6,997.60 | 46,416 | 2023-03-24 | Filing | |
| $0.86 | 35,002 | $30,206.51 | 35,002 | 2023-03-23 | Filing | |
| $0.86 | 35,000 | $30,159.50 | 226,299 | 2023-03-23 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $194.30 | 9,100 | $1,768,130.00 | 20,832 | 2025-11-20 | Filing | |
| $193.23 | 977 | $188,788.64 | 29,932 | 2025-11-20 | Filing | |
| $192.53 | 13,339 | $2,568,197.69 | 30,909 | 2025-11-20 | Filing | |
| $190.86 | 1,714 | $327,139.18 | 44,248 | 2025-11-20 | Filing | |
| $192.71 | 2,145 | $413,365.10 | 10,442 | 2025-11-20 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,221,944 | $393,698,137 | 0.01% | |
| 2. | 756,748 | $243,816,638 | 0.01% | |
| 3. | 286,644 | $91,427,530 | 0.1% | |
| 4. | 172,484 | $55,572,620 | 0.09% | |
| 5. | 169,902 | $54,740,725 | 0.01% |
News See All
Billionaire Joe Edelman's 10 Stock Picks with Huge Upside Potential
Joseph Edelman, the billionaire chief of New York-based Perceptive Advisors, specializes in the biotechnology and life sciences sectors.
9 Best Upside Stocks to Buy According to Analysts
On April 16, Fundstrat’s Tom Lee joins 'Closing Bell' to discuss what to expect from equity markets going forward.
Praxis Precision Medicines (PRAX) Reports $926M 2025 Cash Balance, Extended Runway
Praxis Precision Medicines Inc. (NASDAQ:PRAX) is one of the best hot stocks to buy according to analysts.
13 Best Hot Stocks to Buy According to Analysts
On March 6, Dan Niles, Niles Investment Management founder, joined 'Power Lunch' on CNBC to discuss the broader market sell-off and provide a cautious outlook on the current market environment.
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Q4 2025 Earnings Call Transcript
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Q4 2025 Earnings Call Transcript February 19, 2026Praxis Precision Medicines, Inc. misses on earnings expectations.
Praxis Precision Medicines, Inc. (PRAX) Gains Analyst Confidence With Ulixacaltamide
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) is one of the best stocks to buy and hold for the next 6 months. On February 10, Guggenheim raised its price target for Praxis Precision Medicines Inc.
Wells Fargo Cautious on Praxis Precision (PRAX) After Recent Revenue Estimates
Praxis Precision Medicines Inc. (NASDAQ:PRAX) is one of the 13 hot stocks to buy with the highest upside potential.
10 Best Stocks to Buy and Hold for the Next 6 Months
Investors are becoming more selective toward tech stocks amid valuation concerns, with the overall market at all-time highs.
Guggenheim Raises Price Target for Praxis Precision Medicines (PRAX)
On February 10, Guggenheim analyst Yatin Suneja raised the price target on Praxis Precision Medicines (NASDAQ:PRAX) from $760 to $800.
Hedge Fund Resource Center